Back
ESC Premium Access

Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH).

Session: Poster session 3 - Pulmonary hypertension: pathophysiology
Topic: Chronic pulmonary hypertension
Speaker: Doctor T. Kramer (Cologne, DE)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Tilmann Kramer

Cologne University Hospital - Heart Center, Cologne (Germany)
0 follower

9 more presentations in this session

Contribution of right ventricular deformation analysis to screening of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease

Speaker: Doctor J. Latal (Olomouc, CZ)

Access
Abstract
Slides
Like
Thumbnail

Role of endothelial transforming growth factor-beta signalling for chronic fibrotic remodelling in murine and human venous thrombosis

Speaker: Professor K. Schaefer (Mainz, DE)

Access
Abstract
Like
Thumbnail

Pulmonary vascular gradients, right ventricular afterload and outcomes in pulmonary hypertension due to left heart disease

Speaker: Associate Professor S. Caravita (Bergamo, IT)

Access
Abstract
Like
Thumbnail

Non invasive discrimination between pre and post capillary pulmonary hypertension : comparison of three published scores

Speaker: Doctor O. Raitiere (Le Havre Cedex, FR)

Access
Abstract
Like
Thumbnail

Pulmonary hypertension due to diastolic dysfunction: a predictive model using the national echo database of australia (NEDA)

Speaker: Doctor K. Chung (PERTH, AU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 3 - Pulmonary hypertension: pathophysiology

Speakers: Doctor T. Kramer, Doctor J. Latal, Professor K. Schaefer, Associate Professor S. Caravita, Doctor O. Raitiere...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources